Contract notice CN3924656 · National Blood Authority
Imported Plasma and Recombinant Products (Factor XI Concentrate)
$8.3m
whole-of-life value, after 1 amendment
+$757k (+10.0%) since first published at $7.6m
- Supplier
- CSL BEHRING (AUSTRALIA) PTY LTD ABN 48160734761
- Agency
- National Blood Authority
- Procurement method
- limited tender
- Reason given
- 10.3.d.ii. Supply by particular business: with no reasonable alternative or substitute: to protect exclusive rights or proprietary information.
- Term
- 2022-10-01 to 2027-06-30
- Published
- 2022-11-02
- Category (UNSPSC)
- 85100000
- Agency reference
- CBP-CON-00173
Value by financial year
The total value spread evenly from start to end date. estimate: annualised
| Financial year | Estimated amount |
|---|---|
| 2022-23 | $1.3m |
| 2023-24 | $1.8m |
| 2024-25 | $1.8m |
| 2025-26 | $1.8m |
| 2026-27 | $1.8m |
Published versions
Every version of this notice we have loaded. Source: AusTender OCDS API.
| Date | Version | Value |
|---|---|---|
| 2022-11-02 | original notice | $7.6m |
| 2026-07-16 | amendment | $8.3m |